For years, the phrase “hardening of the arteries” scared the life out of patients and doctors alike. Atherosclerosis—the silent, steady build-up of plaque inside your arteries—was seen as a one-way street to heart attacks, strokes, and a lifetime of pills. But as research has gotten more sophisticated, the conversation has shifted. People want to know: can atherosclerosis be reversed, or is it just wishful thinking?
This is your no-nonsense, evidence-backed, and brutally honest deep dive into the science, the hope, and the hype surrounding the reversal of atherosclerosis.
What Exactly Is Atherosclerosis?
Atherosclerosis starts with irritation or damage to the inner lining of your arteries. High blood pressure, smoking, high blood sugar, and especially LDL (“bad”) cholesterol all contribute. Over years—or even decades—tiny injuries invite cholesterol, fats, calcium, and immune cells to pile up under the artery lining. The result: a plaque that narrows and stiffens the artery, forming a kind of biological “scar tissue” that can grow, rupture, or calcify (Mayo Clinic).
The scariest part? Most people have no symptoms until a plaque ruptures or blocks off blood flow—meaning the first sign could be a heart attack or stroke.
The Old View: Once Clogged, Always Clogged?
For decades, textbooks said atherosclerosis was irreversible. Doctors focused on slowing the progression—controlling cholesterol, blood pressure, and blood sugar; encouraging people to quit smoking; and getting them moving.
By the 1980s, angioplasty and bypass surgery could “detour” around blocked arteries, but didn’t clear out the plaque itself. The consensus: you could stabilize the problem, but you couldn’t fix it.
The New Evidence: Can Plaque Actually Shrink?
Here’s where things get interesting.
Medications That Do More Than Slow the Disease
Statins Take Center Stage
Statins (like atorvastatin, rosuvastatin) were game-changers. They lower LDL cholesterol, reduce inflammation, and have been shown to decrease heart attacks and strokes. But could they reverse plaque?
The ASTEROID trial in 2006 was a bombshell. Using high-dose rosuvastatin, researchers saw a measurable—though modest—reduction in plaque volume inside coronary arteries, as visualized by intravascular ultrasound. Not enough to “unclog” arteries entirely, but enough to prove that plaque regression was possible (NEJM).
Other studies have backed this up: statins, especially when LDL is driven very low (under 70 mg/dL), reduce the fatty, “soft” component of plaque, making it less likely to rupture.
PCSK9 Inhibitors: The New Kids on the Block
Drugs like evolocumab and alirocumab can drop LDL to previously unheard-of levels. Early studies show adding these to statins can shrink plaque volume even further, though (again) the change is modest (JAMA).
Anti-Inflammatory Drugs
The CANTOS trial tested canakinumab, targeting inflammation without touching cholesterol. The results: fewer heart attacks, fewer strokes, and a suggestion that “quieting” inflammation also stabilizes dangerous plaques (NEJM). Still, these drugs are costly and not for everyone.
Lifestyle Change: The Ornish and Esselstyn Protocols
The Ornish Study
Dr. Dean Ornish’s research in the 1990s turned cardiology on its ear. He put patients with heart disease on a strict, plant-based diet (less than 10% of calories from fat), coupled with moderate exercise, stress management, and group support. Over a year, angiograms showed slight regression of plaque in the treatment group, while the control group worsened (Lancet). At five years, the difference persisted—but only for those who stuck to the program.
Caldwell Esselstyn’s Cleveland Clinic Experience
Dr. Esselstyn’s patients followed an even stricter plant-based, oil-free diet. Many saw their angina vanish and, in some cases, had reversal of blockages on follow-up imaging (Cleveland Clinic).
Real Talk About Lifestyle Interventions
These changes are drastic. Very few people stick to them long-term. But for those who do, the results are remarkable—reduced symptoms, fewer procedures, and, in select cases, actual plaque regression.
What About Supplements and “Natural” Cures?
- Niacin: Once hailed as a wonder drug for raising HDL, large trials have shown no benefit and plenty of side effects.
- Fish Oil: Modest benefit in high-risk people, but not a plaque-melting miracle.
- Chelation Therapy, Cleanses, “Artery Flushes”: Chelation therapy with EDTA has shown some credibility. I've personally talked with many patients who swear by EDTA chelation while I myself was being chelated. People who couldn't walk to their mail boxes to get the mail were again playing golf after being chelated. Cleanses and artery flushes show No credible evidence, and some are downright dangerous. Steer clear.
- Nattokinase: Yes, evidence suggests that high-dose nattokinase (around 10,800 FU/day) can significantly reduce and potentially reverse plaque buildup in arteries, with studies showing reductions in carotid plaque size by up to 36% or more over 12 months. It works by decreasing carotid intima-media thickness, managing atherosclerosis, lowering lipids, and providing fibrinolytic, anti-inflammatory, and anti-atherosclerotic effects. More on Nattokinase
What Does “Reversal” Actually Mean?
Here’s the catch: most plaque regression is mild. We’re talking millimeters—enough to lower risk, not enough to turn a 70-year-old’s arteries back into a teenager’s. More often, the goal is stabilization—making plaques less likely to rupture, even if they don’t shrink dramatically.
But in the world of heart disease, stabilization IS a kind of reversal. If you can lower your risk of a heart attack, live longer, and feel better, that’s a win.
The Numbers: What Can You Really Expect?
- Statins: 0–2% reduction in plaque volume per year in aggressive therapy groups.
- PCSK9 inhibitors + statins: Up to 1% additional reduction.
- Ornish/Esselstyn lifestyle: 2–8% regression in select motivated patients, especially if started early and followed strictly.
- Most people: Significant risk reduction, even if the arteries themselves don’t look much different on scans.
Who Should Aim For Reversal?
- High-risk patients: Those with known heart disease, diabetes, or multiple risk factors benefit the most.
- Highly motivated individuals: Willing to make major lifestyle changes, under medical supervision.
- Early/intermediate disease: The earlier you start, the better your odds.
The Bottom Line: Can You Reverse Atherosclerosis?
Yes, but with caveats. True, complete reversal is rare. But you can shrink plaques a bit, stabilize them a lot, and dramatically cut your risk with a combination of medication and lifestyle overhaul.
Don’t buy into miracle cures or quick fixes. The science says real progress is possible—with consistent effort, medical oversight, and, frankly, some stubbornness.
Credits
- Mayo Clinic – Atherosclerosis Overview
- NEJM – Intensive Statin Therapy (ASTEROID Trial)
- Lancet – Ornish Lifestyle Heart Trial
- JAMA Cardiology – GLAGOV PCSK9 Study
- NEJM – CANTOS Anti-inflammatory Therapy
- Cleveland Clinic – Atherosclerosis
Final Word
If you’re staring down a diagnosis of atherosclerosis, don’t panic—but don’t settle, either. You can tilt the odds in your favor, sometimes even nudge those plaques backward, if you’re willing to do the work. And even if you can’t get rid of every last bit of plaque, you can almost always make your arteries—and your future—a whole lot safer.
